Molina (MOH) reported earnings 30 days ago. What's next for the stock?
MOH expects total membership to be at 5.9 million by 2025-end.
Molina Healthcare, Inc. (NYSE:MOH ) Q4 2024 Earnings Conference Call February 6, 2025 8:00 AM ET Company Participants Jeffrey Geyer - Head of Investor Relations Joe Zubretsky - President and Chief Executive Officer Mark Keim - Senior Executive Vice President and Chief Financial Officer Conference Call Participants Andrew Mok - Barclays Stephen Baxter - Wells Fargo Josh Raskin - Nephron Research Sarah James - Cantor Fitzgerald Justin Lake - Wolfe Research A.J. Rice - UBS Adam Ron - Bank of America Christian Borgmeyer - TD Cowen Michael Hall - Baird Scott Fidel - Stephens Operator Good day and welcome to Molina Healthcare Fourth Quarter 2024 Earnings Conference Call.
While the top- and bottom-line numbers for Molina (MOH) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Molina (MOH) came out with quarterly earnings of $5.05 per share, missing the Zacks Consensus Estimate of $5.81 per share. This compares to earnings of $4.38 per share a year ago.
Molina Healthcare reported higher-than-expected costs tied to its government-backed Medicaid plans, sending the health insurer's shares down nearly 9% in after-hours trading.
MOH's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Get a deeper insight into the potential performance of Molina (MOH) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
A handful of health care stocks got a boost after President Trump said Friday his administration would “love and cherish Social Security, Medicare, and Medicaid.”
Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Michael Burry's significant investment in Molina Healthcare highlights its impressive growth rates and undervalued stock, trading at 12x forward earnings and below 7x forward EBITDA. Molina Healthcare's revenue and EPS have seen substantial growth, but the company faces challenges with Medicaid membership declines and high Medical Care Ratios. The company is pursuing both organic growth and acquisitions, with a strong balance sheet and liquidity.
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.